bortezomib
bortezomib is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including Bortezomib, bortezomib, BORTEZOMIB. Available dosage forms: injection, powder, lyophilized, for solution, powder, injection.
Drug Details
- Generic Name
- bortezomib
- Brand Names
- Bortezomib, bortezomib, BORTEZOMIB, VELCADE
- Application Number
- ANDA211898
- Sponsor
- Waverley Pharma Inc
- NDC Codes
- 11
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, POWDER, INJECTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Active Ingredients
- BORTEZOMIB
Indications and Usage
1 INDICATIONS AND USAGE Bortezomib for Injection is a proteasome inhibitor indicated for: treatment of adult patients with multiple myeloma ( 1.1 ) treatment of adult patients with mantle cell lymphoma ( 1.2 ) 1.1 Multiple Myeloma Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma. 1.2 Mantle Cell Lymphoma Bortezomib for Injection is indicated for the treatment of adult patients with mantle cell lymphoma.